Skip to main content

Amlodipine and Olmesartan Medoxomil

NDC 69238-2675 · Amneal Pharmaceuticals NY LLC

Generic nameAmlodipine and Olmesartan Medoxomil
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL
Strength5; 20 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
Marketing categoryANDA

Packages

69238-2675-1 — 1000 TABLET, FILM COATED in 1 BOTTLE (69238-2675-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68788-8818 — Amlodipine Besylate and Benazepril Hydrochloride, 68788-9345 — Amlodipine besylate, 69097-126 — AMLODIPINE BESYLATE, 69097-127 — AMLODIPINE BESYLATE, 69097-128 — AMLODIPINE BESYLATE, 69097-836 — Amlodipine Besylate, 69097-837 — Amlodipine Besylate, 69097-838 — Amlodipine Besylate, 69238-2673 — Amlodipine and Olmesartan Medoxomil, 69238-2674 — Amlodipine and Olmesartan Medoxomil, 69238-2676 — Amlodipine and Olmesartan Medoxomil, 69238-2684 — Amlodipine Besylate and Benazepril Hydrochloride, 69238-2685 — Amlodipine Besylate and Benazepril Hydrochloride, 69238-2686 — Amlodipine Besylate and Benazepril Hydrochloride, 69238-2687 — Amlodipine Besylate and Benazepril Hydrochloride, 69584-021 — AMLODIPINE BESYLATE, 69584-022 — AMLODIPINE BESYLATE, 69584-023 — AMLODIPINE BESYLATE, 70436-014 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-015 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, +720 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels